Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
Clinical trial NCT06339086 · UNKNOWN
Trial details
- NCT number
- NCT06339086
- Sponsor
- Chengdu Brilliant Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-08-30
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.